Komori
COSMOS Pharmaceutical (3349) · FactSales Mix by Product Category Updated

Revenue Mix by Product Category

First written in FY2022-Q2. . Latest entry: FY2026.

16entries
5years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q2 – FY20262022: 420222023: 420232024: 320242025: 220252026: 32026
Same theme, other companies
Disclosure of revenue disaggregated by product categoryA theme 59 companies write about · 1 as a headwind · 1 as a tailwind

29 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 59 companies compared. The sentences above are computed from all 59.
Full recordFilings, disclosures and news, newest first
  1. FY2026Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　143,923 Cosmetics　97,898 Sundries　157,604 General food　691,670 Other　8,487 Revenue from contracts with customers　1,099,583」

    The company disclosed its sales mix for the consolidated fiscal year as general food of ¥691,670 million, sundries of ¥157,604 million, pharmaceuticals of ¥143,923 million, cosmetics of ¥97,898 million, and other products of ¥8,487 million.
  2. 2026-04-13OtherEarnings

    「General food products 456,724 60.7 510,640 63.0」

    Cumulative third-quarter sales of general food products and their composition ratio were updated to ¥510,640 million and 63.0%, respectively.
  3. FY2026-H1Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 71,762 Cosmetics 48,109 Sundries 75,751 General food 337,393 Other 4,157 Revenue from contracts with customers 537,175」

    The company disclosed the breakdown of revenue from contracts with customers of ¥537,175 million for the interim consolidated period, comprising general food of ¥337,393 million, sundries of ¥75,751 million, pharmaceuticals of ¥71,762 million, cosmetics of ¥48,109 million, and other products of ¥4,157 million.
  4. FY2025Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　140,639 Cosmetics　93,107 Sundries　150,996 General food　619,082 Other　7,565 Revenue from contracts with customers　1,011,390」

    The company disclosed its sales mix for the consolidated fiscal year as general food of ¥619,082 million, sundries of ¥150,996 million, pharmaceuticals of ¥140,639 million, cosmetics of ¥93,107 million, and other products of ¥7,565 million.
  5. FY2025-H1Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 71,251 Cosmetics 47,128 Sundries 76,624 General food 307,193 Other 3,739 Revenue from contracts with customers 505,936」

    The company disclosed the breakdown of revenue from contracts with customers of ¥505,936 million for the interim consolidated period, comprising general food of ¥307,193 million, sundries of ¥76,624 million, pharmaceuticals of ¥71,251 million, cosmetics of ¥47,128 million, and other products of ¥3,739 million.
  6. FY2024Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　136,642 Cosmetics　89,709 Sundries　148,822 General food　582,766 Other　7,047 Revenue from contracts with customers　964,989」

    The company disclosed its sales mix for the consolidated fiscal year as general food of ¥582,766 million, sundries of ¥148,822 million, pharmaceuticals of ¥136,642 million, cosmetics of ¥89,709 million, and other products of ¥7,047 million.
  7. FY2024-Q3Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 102,036 Cosmetics 66,221 Sundries 111,334 General food 430,522 Other 5,197 Revenue from contracts with customers 715,311」

    The company disclosed the breakdown of revenue from contracts with customers of ¥715,311 million for the cumulative third quarter, comprising general food of ¥430,522 million, sundries of ¥111,334 million, pharmaceuticals of ¥102,036 million, cosmetics of ¥66,221 million, and other products of ¥5,197 million.
  8. FY2024-Q2Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 68,940 Cosmetics 44,087 Sundries 73,609 General food 286,349 Other 3,443 Revenue from contracts with customers 476,430」

    The company disclosed the breakdown of revenue from contracts with customers of ¥476,430 million for the cumulative second quarter, comprising general food of ¥286,349 million, sundries of ¥73,609 million, pharmaceuticals of ¥68,940 million, cosmetics of ¥44,087 million, and other products of ¥3,443 million.
  9. FY2024-Q1Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 36,254 Cosmetics 22,303 Sundries 36,614 General food 144,749 Other 1,730 Revenue from contracts with customers 241,653」

    The company disclosed the breakdown of revenue from contracts with customers of ¥241,653 million for the first quarter, comprising general food of ¥144,749 million, sundries of ¥36,614 million, pharmaceuticals of ¥36,254 million, cosmetics of ¥22,303 million, and other products of ¥1,730 million.
  10. FY2023Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　125,851 Cosmetics　80,763 Sundries　131,077 General food　483,892 Other　6,112 Revenue from contracts with customers　827,697」

    The company disclosed the breakdown of revenue from contracts with customers of ¥827,697 million for the consolidated fiscal year, comprising general food of ¥483,892 million, sundries of ¥131,077 million, pharmaceuticals of ¥125,851 million, cosmetics of ¥80,763 million, and other products of ¥6,112 million.
  11. FY2023-Q3Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 93,408 Cosmetics 59,111 Sundries 97,500 General food 351,771 Other 4,510 Revenue from contracts with customers 606,302」

    The company disclosed the breakdown of revenue from contracts with customers of ¥606,302 million for the cumulative third quarter, comprising general food of ¥351,771 million, sundries of ¥97,500 million, pharmaceuticals of ¥93,408 million, cosmetics of ¥59,111 million, and other products of ¥4,510 million.
  12. FY2023-Q2Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 63,051 Cosmetics 39,727 Sundries 64,164 General food 234,055 Other 3,017 Revenue from contracts with customers 404,016」

    The company disclosed the breakdown of revenue from contracts with customers of ¥404,016 million for the cumulative second quarter, comprising general food of ¥234,055 million, sundries of ¥64,164 million, pharmaceuticals of ¥63,051 million, cosmetics of ¥39,727 million, and other products of ¥3,017 million.
  13. FY2023-Q1Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals 33,950 Cosmetics 20,169 Sundries 31,877 General food 118,599 Other 1,526 Revenue from contracts with customers 206,122」

    The company disclosed the breakdown of revenue from contracts with customers of ¥206,122 million for the cumulative first quarter, comprising general food of ¥118,599 million, pharmaceuticals of ¥33,950 million, sundries of ¥31,877 million, cosmetics of ¥20,169 million, and other products of ¥1,526 million.
  14. FY2022Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　116,509 Cosmetics　73,991 Sundries　121,440 General food　437,118 Other　6,353 Revenue from contracts with customers　755,414」

    The company disclosed the breakdown of revenue from contracts with customers of ¥755,414 million for the consolidated fiscal year, comprising general food of ¥437,118 million, sundries of ¥121,440 million, pharmaceuticals of ¥116,509 million, cosmetics of ¥73,991 million, and other products of ¥6,353 million.
  15. FY2022-Q3Sales Mix by Product Category UpdatedAnnual report

    「Pharmaceuticals　86,216 Cosmetics　54,107 Sundries　90,967 General food　322,791 Other　4,803 Revenue from contracts with customers　558,885」

    The company disclosed the breakdown of revenue from contracts with customers of ¥558,885 million for the cumulative third quarter, comprising general food of ¥322,791 million, sundries of ¥90,967 million, pharmaceuticals of ¥86,216 million, cosmetics of ¥54,107 million, and other products of ¥4,803 million.
  16. FY2022-Q2First statedAnnual report

    「General food products: processed foods, daily foods, seasonings, confectionery, beverages and alcohol ¥214,061 million」

    The company disclosed the product mix of revenue from contracts with customers of ¥371,138 million for the cumulative second quarter, comprising general food of ¥214,061 million, sundries of ¥59,680 million, pharmaceuticals of ¥58,354 million, cosmetics of ¥35,763 million, and other products of ¥3,277 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet. It last moved in the Earnings of 2026-04-13: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revenue Mix by Product Category | COSMOS Pharmaceutical Corporation (3349) | Komori